329 related articles for article (PubMed ID: 16757329)
21. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
22. Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4.
Yang YH; Wang Y; Lam KS; Yau MH; Cheng KK; Zhang J; Zhu W; Wu D; Xu A
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):835-40. PubMed ID: 18340008
[TBL] [Abstract][Full Text] [Related]
23. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells.
Hellmann J; Rommelspacher H; Mühlbauer E; Wernicke C
Dev Neurosci; 2010 Mar; 32(1):33-46. PubMed ID: 19955695
[TBL] [Abstract][Full Text] [Related]
24. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Gollob JA; Wilhelm S; Carter C; Kelley SL
Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
[TBL] [Abstract][Full Text] [Related]
25. Raf kinase inhibitory protein inhibits beta-cell proliferation.
Zhang L; Fu Z; Binkley C; Giordano T; Burant CF; Logsdon CD; Simeone DM
Surgery; 2004 Sep; 136(3):708-15. PubMed ID: 15349122
[TBL] [Abstract][Full Text] [Related]
26. Raf: a strategic target for therapeutic development against cancer.
Beeram M; Patnaik A; Rowinsky EK
J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
[TBL] [Abstract][Full Text] [Related]
27. Lack of hippocalcin causes impairment in Ras/extracellular signal-regulated kinase cascade via a Raf-mediated activation process.
Noguchi H; Kobayashi M; Miwa N; Takamatsu K
J Neurosci Res; 2007 Mar; 85(4):837-44. PubMed ID: 17279541
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein.
Trakul N; Rosner MR
Cell Res; 2005 Jan; 15(1):19-23. PubMed ID: 15686621
[TBL] [Abstract][Full Text] [Related]
29. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
30. Second nature: biological functions of the Raf-1 "kinase".
Baccarini M
FEBS Lett; 2005 Jun; 579(15):3271-7. PubMed ID: 15943972
[TBL] [Abstract][Full Text] [Related]
31. Presenilin acts as a positive regulator of basal level activity of ERK through the Raf-MEK1 signaling pathway.
Kim MY; Park JH; Choi EJ; Park HS
Biochem Biophys Res Commun; 2005 Jul; 332(2):609-13. PubMed ID: 15896720
[TBL] [Abstract][Full Text] [Related]
32. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
Kolch W
Nat Rev Mol Cell Biol; 2005 Nov; 6(11):827-37. PubMed ID: 16227978
[TBL] [Abstract][Full Text] [Related]
33. Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Mc Henry KT; Montesano R; Zhu S; Beshir AB; Tang HH; Yeung KC; Fenteany G
J Cell Biochem; 2008 Feb; 103(3):972-85. PubMed ID: 17668446
[TBL] [Abstract][Full Text] [Related]
34. RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade.
Pleschka S
Biol Chem; 2008 Oct; 389(10):1273-82. PubMed ID: 18713014
[TBL] [Abstract][Full Text] [Related]
35. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
37. Sustained activation of Src-family tyrosine kinases by ischemia: a potential mechanism mediating extracellular signal-regulated kinase cascades in hippocampal dentate gyrus.
Guo J; Wu HW; Hu G; Han X; De W; Sun YJ
Neuroscience; 2006 Dec; 143(3):827-36. PubMed ID: 17000055
[TBL] [Abstract][Full Text] [Related]
38. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
Park S; Yeung ML; Beach S; Shields JM; Yeung KC
Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
[TBL] [Abstract][Full Text] [Related]
39. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
Friday BB; Adjei AA
Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
[TBL] [Abstract][Full Text] [Related]
40. A proteomic approach in investigating the hepatoprotective mechanism of Schisandrin B: role of raf kinase inhibitor protein.
Chen Y; Ip SP; Ko KM; Poon TC; Ng EW; Lai PB; Mao QQ; Xian YF; Che CT
J Proteome Res; 2011 Jan; 10(1):299-304. PubMed ID: 21155602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
